Page last updated: 2024-08-21

dihydroergotamine and ergonovine

dihydroergotamine has been researched along with ergonovine in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-199022 (81.48)18.7374
1990's1 (3.70)18.2507
2000's4 (14.81)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K1
Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K1
Kerekes, A; Policova, Z; Sirek, A; Sirek, OV1
Angus-Leppan, H; Boers, PM; Lambert, GA; Lowy, AJ; Zagami, AS1
Sakanashi, M; Yonemura, KI1
Johnson, ZB; Moubarak, AS; Rosenkrans, CF1
SIMKOVA, M1
CAMINITI, R; CORELLI, D1
HORTON, BT; PETERS, GA1
HERSCHBERG, AD1
LEIBETSEDER, FJ1
JACOB, O1
VODOPIVEC, M1
CALDWELL, WG1
POLLOCK, LA2
GAROBY, JP; MAIRE, R; REDER, J1
DE BOER, J; VAN DONGEN, K1
MOHME, E1
Callaway, TR; Edrington, TS; Looper, ML; Moubarak, AS; Rosenkrans, CF1
ABREU, BE; LIDDLE, GW1
KOPPANYI, T1
DANNENBERG, T1
GOTTHELF, EJ1
FRIEDMAN, DA; FRIEDMAN, MD1
ORTH, OS1

Other Studies

27 other study(ies) available for dihydroergotamine and ergonovine

ArticleYear
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
    Molecular pharmacology, 2002, Volume: 61, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine

2002
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine

2002
Effect of ergot alkaloids on sulfonylurea-stimulated insulin secretion in dogs.
    Pharmacology, 1977, Volume: 15, Issue:3

    Topics: Animals; Blood Glucose; Dihydroergotamine; Dihydroergotoxine; Dogs; Ergonovine; Ergot Alkaloids; Ergotamine; Female; Injections, Intravenous; Insulin; Insulin Secretion; Male; Secretory Rate; Sulfonylurea Compounds

1977
The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids.
    Brain research, 1992, Dec-04, Volume: 597, Issue:2

    Topics: Action Potentials; Animals; Cats; Cranial Sinuses; Dihydroergotamine; Electric Stimulation; Ergonovine; Ergotamine; Evoked Potentials; Neural Pathways; Spinal Cord

1992
On the mode of action of ergometrine in the isolated dog coronary artery.
    European journal of pharmacology, 1980, Jun-13, Volume: 64, Issue:2-3

    Topics: Animals; Arteries; Coronary Vessels; Dihydroergotamine; Dogs; Dose-Response Relationship, Drug; Ergonovine; In Vitro Techniques; Methysergide; Phenoxybenzamine; Phentolamine; Receptors, Serotonin; Serotonin; Vasoconstriction

1980
Modulation of cytochrome P450 metabolism by ergonovine and dihydroergotamine.
    Veterinary and human toxicology, 2003, Volume: 45, Issue:1

    Topics: Animals; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dihydroergotamine; Dose-Response Relationship, Drug; Ergonovine; Ergot Alkaloids; Infusions, Parenteral; Isomerism; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley

2003
[Therapy of herpetic diseases of the cornea with dihydroergotamine and gynergen].
    Ceskoslovenska oftalmologie, 1950, Volume: 6, Issue:3

    Topics: Cornea; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Humans

1950
[Graphic study on the motility of the stomach in hyperthyroidism; action of dihydroergotamine].
    Rassegna di neurologia vegetativa, 1950, Volume: 8, Issue:2

    Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Hyperthyroidism; Stomach

1950
Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine.
    The Journal of laboratory and clinical medicine, 1950, Volume: 36, Issue:6

    Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Headache

1950
[Treatment of migraine by dihydroergotamine].
    Paris medical, 1950, Nov-11, Volume: 40, Issue:42

    Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders

1950
[Changes effected by adrenalin and dihydroergotamine during the first phase of blood coagulation].
    Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete, 1951, Volume: 32, Issue:3

    Topics: Blood Coagulation; Dihydroergotamine; Epinephrine; Ergonovine; Ergot Alkaloids

1951
[Experiences with dihydroergotamine in otorhinology].
    Zeitschrift fur Laryngologie, Rhinologie, Otologie und ihre Grenzgebiete, 1951, Volume: 30, Issue:3

    Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Otolaryngology

1951
[Effect of dihydroergotamine and hydergin on urinary excretion of potassium].
    Archives internationales de pharmacodynamie et de therapie, 1951, Volume: 87, Issue:1-2

    Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Potassium

1951
[First experiences with dihydroergotamine in labor].
    Ceskoslovenska gynekologie, 1951, Volume: 16, Issue:4

    Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Female; Humans; Labor, Obstetric; Pregnancy; Work

1951
The treatment of postlumbar puncture headache with DHE-45 (dihydroergotamine).
    Western journal of surgery, obstetrics, and gynecology, 1950, Volume: 58, Issue:1

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Headache; Post-Dural Puncture Headache; Punctures

1950
Further experience with dihydroergotamine methanesulfonate in the treatment of migraine; with a note on the use of cafergone.
    Annals of western medicine and surgery, 1949, Volume: 3, Issue:11

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders

1949
[Effects of dihydroergotamine in 2 cases of duodenal ulcers].
    Cahiers medicaux de l'union francaise; revue medico-chirurgicale de la France d'outre-mer, 1950, Volume: 5, Issue:37

    Topics: Claviceps; Dihydroergotamine; Duodenal Ulcer; Ergonovine; Ergot Alkaloids; Humans; Peptic Ulcer

1950
Experiments with dihydroergotamine.
    Archives internationales de pharmacodynamie et de therapie, 1948, Nov-01, Volume: 77, Issue:4

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids

1948
Effect of dihydroergotamine on the oxygen consumption; experiments on cats.
    Acta physiologica Scandinavica, 1949, Volume: 18, Issue:1

    Topics: Animals; Cats; Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Oxygen; Oxygen Consumption

1949
Effects of the ergot alkaloids dihydroergotamine, ergonovine, and ergotamine on growth of Escherichia coli O157:H7 in vitro.
    Foodborne pathogens and disease, 2008, Volume: 5, Issue:5

    Topics: Analysis of Variance; Animals; Cattle; Cattle Diseases; Colony Count, Microbial; Dihydroergotamine; Ergonovine; Ergotamine; Escherichia coli Infections; Escherichia coli O157; Festuca; Food Microbiology; Regression Analysis; Rumen

2008
Effects of amphetamine, dihydroergotamine, and methadon on human cerebral blood flow and oxygen uptake.
    Federation proceedings, 1948, Volume: 7, Issue:1 Pt 1

    Topics: Amphetamine; Amphetamines; Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Methadone; Oxygen

1948
Dihydroergotamine (D.H.E. 45), a new and effective drug in the treatment of migraine.
    Rocky Mountain medical journal, 1946, Volume: 43, Issue:11

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Migraine Disorders

1946
A new artificial ergot derivative, dehydroergotamine (DHE45).
    The Anatomical record, 1946, Volume: 96, Issue:4

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans

1946
Comparison of dihydroergotamine, ergotamine and other agents in the treatment of migraine.
    Permanente Foundation medical bulletin, 1946, Volume: 4

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Migraine Disorders

1946
D.H.E. 45 (dihydroergotamine) a new drug in the treatment of migraine.
    Arizona medicine, 1946, Volume: 3

    Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Migraine Disorders

1946
Dihydroergotamine in the treatment of migraine; preliminary clinical observations.
    The Ohio State medical journal, 1945, Volume: 41

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders

1945
Studies of the sympathicolytic drug dihydroxyergotamine, D.H.E.45.
    Federation proceedings, 1946, Volume: 5, Issue:1 Pt 2

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Nervous System; Sympathetic Nervous System

1946